Depressive and anxiety symptoms in patients with Metabolic Syndrome

Authors

  • Lilian Lopes SHAROVSKY Universidade de São Paulo, Faculdade de Medicina, Instituto do Coração do Hospital das Clínicas.
  • Bellkiss Wilma ROMANO Universidade de São Paulo, Faculdade de Medicina, Instituto do Coração do Hospital das Clínicas.

Keywords:

Anxiety, Depression, Metabolic syndrome

Abstract

Depressive symptoms have been associated to the Metabolic Syndrome. Nevertheless, only a few studies have evaluated anxiety and depression concomitantly. The objective of the research was to evaluate the intensity of depressive and anxiety symptoms in patients with Metabolic Syndrome and their relation to demographic variables. A unicenter, transversal study was carried out. A social demographic questionnaire was used. Depressive symptoms were measured with Beck Depression Inventory and anxiety symptoms were measured with Hamilton Anxiety Scale Rate. A total of 103 ambulatory patients, 60 of them men, with mean age 55.4 years (±7,6) with a diagnosis of Metabolic Syndrome were included in the study. Anxiety symptoms of very severe intensity were present in 51.5% (n=53) while severe depressive symptoms in only 5.8% (n=6). Anxiety and depressive symptoms were significantly associated. In this sample, anxiety predominated in relation to the depressive symptoms. The anxiety symptoms were more intense in women and that had low level of education

Downloads

Download data is not yet available.

References

Arenas, M. D., Álvarez-Ude F., Reig-Ferrer A., Zito J.P., Gil, M. T., Carretón, M. A., et al. (2007). Emotional distress and healthrelated quality of life in patients on hemodialysis: The clinical value of COOP-WONCA charts. Journal of Nefhrology, 20(3), 304-310.

Björntorp, P. (2001). Do stress reactions cause abdominal obesities and comorbidities? Obesity Reviews, 2(2), 73-86. Blumenthal, J. A., Lett H. S., Babyak M. A., White W., Smith P. K.,

Mark D. B., et al. (2003). Depression as a risk factor for mortality after coronary artery bypass surgery. The Lancet, 362(9384), 604-609.

Capuron, L., Shaoyong S., Miller A. H., & Bremner J. D. (2008). Depressive symptoms and metabolic syndrome: Is inflammation the underlying link? Biological Psychiatry, 64(10), 896-900.

Carroll, D, Phillips A. C., Thomas G. N., Gale C. R., Deary I., & Batty G. D. (2009). Generalized anxiety disorder is associated with metabolic syndrome in the Vietnam experience. Biological Psychiatry, 66(1), 91-93.

Corella, D., & Ordovas J. M. (2004).The metabolic syndrome: A crossroad for genotype-phenotype associations in atherosclerosis. Current Atherosclerosis Reports, 6(3), 186-196.

Cunha, J. A. (2001). Manual da versão em português das Escalas de Beck. São Paulo: Casa do Psicólogo.

Diaz-Martínez, L., Serrano N., Pinzón J., Mantilla G., Velasco H., Martínez L., et al. (2007). Lack of association between metabolic syndrome and depressive symptoms in Colombian adults. Revista Médica de Chile, 135(8), 990-996.

DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of the anxiety and depression on patient adherence. Archives of International Medicine, 160(14), 2101-2107.

Ford, E. S., Giles W. H., & Dietz W. H. (2002). Prevalence of the metabolic syndrome among US adults: Findings from the third national health and nutrition examination survey. JAMA, 287(3), 356-9.

Grigsby, A. B., Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2002). Prevalence of anxiety in adults with diabetes: A systematic review. Journal of Psychosomatic Research, 53(6),1053-1060.

Grundy, S. M., Cleeman J. I., Daniels S. R., Donato K. A., Eckel R. H., Franklin B. A., et al. (2005). Diagnosis and management of the metabolic syndrome: An American Heart Association/National heart, lung and blood Institute Scientific Statement. Circulation, 112(17), 2735-2752.

Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32(1), 50-55.

Herva, A., Räsänen, P., Miettunen, J., Timonen, M., Läksy, K., Veijola, J., et al. (2006). Co-ocuurrence of metabolic syndrome with depression and anxiety in young adults: The Northern Finland 1966 Birth Cohort Study. Psychosomatic Medicine, 68(2), 213-216.

Huffman, J. C., Smith, F. A., Blais, M. A., Januzzi, J. L., & Fricchione, G. L. (2008). Anxiety, independent of depressive symptoms, is associated with in-hospital cardiac complications after acute myocardial infarction. Journal of Psychosomatic Research, 65(6),557-63.

Keltikangas-Järvinen, L., Räikkönen, K., Hautanen, A., & Adlercreutz, H. (1996). Vital exhaustion, anger expression, and pituitary and adrenocortical hormones implications for the insulin resistance syndrome. Arteriosclerosis Thrombosis Vascular Biology, 16(2), 275-28.

Kinder, L. S., Carnethon, M. R., Palaniappan, L., King, A., & Fortmann, S. P. (2004). Depression and the metabolic syndrome in young adults: Findings from the third national health and nutition examinationg survey. Psychosomatic Medicini, 66(3),316-322.

Kinrys, G., & Wygant, L. E. (2005). Anxiety disorders in women: Does gender matter to treatment? Revista Brasileira de Psiquiatria, 27(Suppl.2), 43-50.

Koponen, H., Jokelainnen, J., Keinänen-Kiukaanniemi, S., Kumpusalo, E., & Vanhala, M. (2007). Metabolic syndrome predisposes to depressive symptoms: A population-based 7-year follow-up study. The Journal Clinical Psychiatry, 69(2): 178-182.

Lipp, M. E. N., Pereira, M. M. B., Justo, A. P., & Matos, T. M. G. (2006). Cardiovascular reactivity in hypertensives: Differential effect of expressing and inhibiting emotions during moments of interpersonal stress. Spanish Journal of Psychology, 9(2). Retrieved May 4, 2007, from <http://www.ucm.es/info/Psi/docs/journal/v9_n2_2006//art154.pdf>.

Maragno, L., Goldbaum M., Gianini, R. J., Novaes, H. M. D., & César, C. L. G. (2006). Prevalence of common mental disorders in a population covered by the Family Health Program (QUALIS) in São Paulo, Brazil. Cadernos de Saúde Pública, 22(8), 1639-1648. Retrieved October 18, 2013, from <http://www.scielosp.org>. doi: 10.1590/S0102-311X2006000800012.

National Cholesterol Education Program. (2001). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. JAMA, 285(19), 2486-2497.

Räikkönnen, K., Mattews, K. A., & Kuller, L. H. (2002). The relationship between psychological risk attributes and the metabolic syndrome in healthy women: Antecedent or consequence? Metabolism, 51(12), 1573-1577.

Skilton, M. R., Moulin P. P., & Terra, J. L. (2007). Association between anxiety, depression, and metabolic syndrome. Biological Psychiatry, 62(11), 1251-1257.

Sociedade Brasileira de Hipertensão, (2004). I Diretriz brasileira de diagnóstico e tratamento da síndrome metabólica. Hipertensão, 7(4), 124-159.

Tully, P. J., Baker, R. A., & Knight, J. L. (2008). Anxiety and depression as a risk factor for mortality after coronary bypass surgery. Journal of Psychosomatic Research, 64(3), 285-90.

Vaccarino, V., McClure C., Johnson D., Sheps D. S., Bittner V., Rutledge T., et al. (2008). Depression, metabolic syndrome and cardiovascular disease. Psychosomatic Medicine, 70(1), 40-48.

Van Praag, H. M. (2005). Can stress cause depression? The World Journal Biological Psychiatry, 6(Suppl.2), 5-22. Wottrich, S. H., Ávila C. M., Machado S. G., Dillenburg D., Kuhl C. P., Irigoyen M. C., et al. (2011). Gênero e manifestação de stress em hipertensos. Estudos de Psicologia (Campinas), 28(1), 27-34. doi: 10.1590/S0103-166X2011000100003.

Downloads

Published

2013-12-31

How to Cite

SHAROVSKY, L. L., & ROMANO, B. W. (2013). Depressive and anxiety symptoms in patients with Metabolic Syndrome. Psychological Studies, 30(4). Retrieved from https://periodicos.puc-campinas.edu.br/estpsi/article/view/8705

Issue

Section

PSYCHOLOGICAL TREATMENT AND PREVENTION